diketopiperazine


Also found in: Acronyms, Encyclopedia, Wikipedia.

di·ke·to·pi·per·a·zine

(dī-kē′tō-pī-pĕr′ə-zēn′)
n.
1. A cyclic dipeptide formed by the dehydration of two molecules of glycine.
2. Any of various cyclic organic compounds formed by the dehydration of alpha-amino acids other than glycine.
References in periodicals archive ?
NPI-2358: A Novel Diketopiperazine, Induces Tubulin Depolymerization In Vitro and Tumor Vascular Collapse In Vivo"
This active component was isolated and identified as Cyclo (L-Leu-L-Arg) (1), a diketopiperazine derivative, possessing antibacterial and antifungal activity.
Based on the 1H, 13C NMR, and 2D (H,H COSY, HMQC, HMBC, and NOE) spectra and comparison with our recently published one [10], compound (1) was deduced as Cyclo (L-Leu- L-Arg), a diketopiperazine derivative (Fig.
The company said that the protected compositions contain either DA-DKP, a cyclic dipeptide diketopiperazine, which is the active ingredient of Ampion, but also extend to many other diketopiperizines.
8 December 2011 - US Ampio Pharmaceuticals Inc (NASDAQ:AMPE), a specialist in discovery and development of new uses for approved drugs and new molecular entities (NMEs), said yesterday it had obtained a European patent with broad claims covering compositions containing DA-DKP, a cyclic dipeptide diketopiperazine that is Ampion's active ingredient.
Under particular conditions (extreme pH, high temperature, lengthy storage times), APM may be contaminated by the diketopiperazine (DKP) cycloaspartylphenylalanine (Butchko et al.
Ampio Pharmaceuticals Inc (Nasdaq: AMPE), a developer of proprietary drugs, on Wednesday said that it has received notification of the granting of a European patent with broad claims directed to compositions containing DA-DKP, a cyclic dipeptide diketopiperazine which is the active ingredient of its key drug Ampion.